David Olsen

Dave joins AgaMatrix with 25 years of experience as a Regulatory Affairs and Quality professional in the IVD, medical devices, biotechnology and biologics environment. Dave holds extensive experience in new product development and licensure within the U.S., Canada, European Union, Brazil, India and China. Prior to joining WaveForm Diabetes, Dave served as Director of Regulatory Affairs, Clinical Affairs and Quality Assurance at Harvard Apparatus Regenerative Technology, Inc., a Holliston, Massachusetts biotechnology company specializing in the development of cell-based tracheal prostatic.

Among his previous roles, Dave served as Vice President, Corporate Regulatory and Quality for five years at SeraCare Life Sciences, Inc., a $60 million IVD biotechnology company specializing in the manufacture of serological and nucleic acid controls and reference materials. Dave has also held executive and management positions with Defibtech, LLC, American Red Cross, and C.R. Bard, Inc.